Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ventricular arrhythmia/cardiac arrest, an investigator reported at the 62 nd European Renal ...

S.F. Holding Co., Ltd. (002352.SZ; 06936.HK, 'SF Holding', 'SF' or the 'the Company') announced a USD 376 million H-share equity placement and concurrent USD 376 million offering of 363-day ...

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...

The Magmaris bioresorbable scaffold was associated with a high restenosis rate 5 years into the MAGSTEMI trial, so a new ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

Diabetic kidney disease (DKD) is a chronic complication of type 1 and type 2 diabetes with albuminuria and progressive kidney failure; about 20%-40% of patients with diabetes will develop some type of ...

Changes in Albuminuria and The Effect of Finerenone on Cardiovascular Outcomes: Insights from FINEARTS-HF. On-demand content will be available for this poster session, available from Friday, June 6, ...

Albuminuria, often measured by urinary albumin-to-creatinine ratio, is as an important marker of kidney function and a predictor of cardiovascular risk, particularly in patients with diabetes.

Patients with persistent albuminuria after induction therapy for ANCA-associated glomerulonephritis are at significantly increased risk for end-stage kidney disease. More than one-third patients ...